University Of Sao Paulo
Clinical trials sponsored by University Of Sao Paulo, explained in plain language.
-
Diabetes drug could help treat bipolar depression
Disease control Not yet recruitingThis study is testing whether empagliflozin, a medication approved for type 2 diabetes, might help reduce depression symptoms in people with bipolar disorder who also have insulin resistance. Twenty adults with bipolar depression will take empagliflozin alongside their current me…
Phase: NA • Sponsor: University of Sao Paulo • Aim: Disease control
Last updated Apr 01, 2026 23:26 UTC
-
Fish oil tested as natural defense against lupus inflammation
Disease control Not yet recruitingThis study is testing whether daily omega-3 fish oil supplements can help control the underlying inflammation and cellular stress in women with lupus. Researchers will give 80 women with stable lupus either omega-3 pills or placebo pills for 12 weeks to see if it improves their b…
Phase: NA • Sponsor: University of Sao Paulo • Aim: Disease control
Last updated Mar 18, 2026 18:25 UTC
-
Smart toothbrush trial aims to transform dental care for kids with autism
Disease control Not yet recruitingThis study is testing whether a smart electric toothbrush with an app and visual picture guides can help children with autism improve their toothbrushing. Researchers will compare the new AI toothbrush system against using a regular manual toothbrush with picture guides. They wil…
Phase: NA • Sponsor: University of Sao Paulo • Aim: Disease control
Last updated Mar 18, 2026 14:41 UTC
-
Fighting the hidden battle: new hope to stop muscle wasting in prostate cancer treatment
Symptom relief Not yet recruitingThis study is testing whether adding a creatine supplement to a supervised weight training program can help men with prostate cancer who are on hormone therapy. The hormone treatment often causes severe muscle loss and weakness. Researchers want to see if this combination can imp…
Phase: NA • Sponsor: University of Sao Paulo • Aim: Symptom relief
Last updated Mar 30, 2026 14:33 UTC